🟢 Anixa Biosciences is trading 6.6% up today as it rebounds from a recent pullback amid trial momentum

Anixa Biosciences is trading at $3.26 (up 6.6%) in pre-market, rebounding from a 4.97% pullback to $3.06 on July 10.

• The upward move follows continued investor interest in the company's ovarian cancer CAR-T/CER-T trial updates and recent patent news shared earlier in July.
• Today's price action appears to be a recovery from mid-week profit-taking rather than a response to any new corporate announcements this morning.
• The stock is regaining momentum after several strong sessions earlier in the week were interrupted by the brief Wednesday decline.